Evidence map›Paper›PMID 38429462›Full record

ArticleScientific reports2024

Delineating immune variation between adult and children COVID-19 cases and associations with disease severity.

Alper Cevirgel, Martijn Vos, Anne Floor Holtrop, Lisa Beckers, Daphne F M Reukers, Adam Meijer, Nynke Rots, Josine van Beek, Debbie van Baarle, Jelle de Wit

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alper CevirgelCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Martijn VosCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Anne Floor HoltropCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Lisa BeckersCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Daphne F M ReukersCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Adam MeijerCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Nynke RotsCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Josine van BeekCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Debbie van Baarle *Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Jelle de Wit *Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. jelle.de.wit@rivm.nl.
National Institute for Public Health and the Environment · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 pandemic has emphasized the need to explore how variations in the immune system relate to the severity of the disease. This study aimed to explore inter-individual variation in response to SARS-CoV-2 infection by comparing T cell, B cell, and innate cell immune subsets among primary infected children and adults (i.e., those who had never experienced SARS-CoV-2 infection nor received vaccination previously), with varying disease severity after infection. We also examined immune subset kinetics in convalescent individuals compared to those with persistent infection to identify possible markers of immune dysfunction. Distinct immune subset differences were observed between infected adults and children, as well as among adult cases with mild, moderate, and severe disease. IgM memory B cells were absent in moderate and severe cases whereas frequencies of B cells with a lack of surface immunoglobulin expression were significantly higher in severe cases. Interestingly, these immune subsets remained stable during recovery implying that these subsets could be associated with underlying baseline immune variation. Our results offer insights into the potential immune markers associated with severe COVID-19 and provide a foundation for future research in this area.

Indexed as

COVID-19AdultB-LymphocytesChildHumansKineticsPatient AcuitySARS-CoV-2

Identifiers

PMID38429462
PMCPMC10907598
OpenAlexW4392354364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.